Concurrent high-dose IV Vitamin C (IVC) and docetaxel for metastatic castrate-resistant prostate cancer (mCRPC): A randomized, placebo-controlled, double-blind phase II trial

Authors

• William Kelly

Publication/Presentation Date

10-2023

Volume

34

Issue

2

First Page

992

Last Page

992

Published In/Presented At

https://doi.org/10.1016/j.annonc.2023.09.2781

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article